Financhill
Sell
7

JFTH Quote, Financials, Valuation and Earnings

Last price:
$0.02
Seasonality move :
-9.31%
Day range:
$0.02 - $0.02
52-week range:
$0.01 - $0.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.93x
P/B ratio:
--
Volume:
11.2K
Avg. volume:
23.4K
1-year change:
-93.38%
Market cap:
$1.6M
Revenue:
$15.9K
EPS (TTM):
-$0.08
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue -- -- -- $1K $15.9K
Revenue Growth (YoY) -- -- -- -- 1433.91%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- $1K $15.9K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $1M $326.4K $274.6K
Other Inc / (Exp) -- -- -- -- -$508K
Operating Expenses -- -- $1M $326.4K $274.6K
Operating Income -- -- -$1M -$325.4K -$258.7K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$1M -$321.1K -$761.3K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $770 $530
Net Income to Company -- -- -$1M -$321.8K -$761.8K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$1M -$321.8K -$761.8K
 
Basic EPS (Cont. Ops) -- -- -$0.10 -$0.03 -$0.06
Diluted EPS (Cont. Ops) -- -- -$0.10 -$0.03 -$0.06
Weighted Average Basic Share -- -- $10.7M $12.9M $13.6M
Weighted Average Diluted Share -- -- $10.7M $12.9M $13.6M
 
EBITDA -- -- -$1M -$325.4K -$258.7K
EBIT -- -- -$1M -$325.4K -$258.7K
 
Revenue (Reported) -- -- -- $1K $15.9K
Operating Income (Reported) -- -- -$1M -$325.4K -$258.7K
Operating Income (Adjusted) -- -- -$1M -$325.4K -$258.7K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- -- -- $620 $5.5K
Revenue Growth (YoY) -- -- -- -- 796.75%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- $620 $5.5K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $52.5K $70.3K $88K
Other Inc / (Exp) -- -- -- -- $1.2K
Operating Expenses -- -- $52.5K $70.3K $88K
Operating Income -- -- -$52.5K -$69.7K -$82.5K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$52.5K -$68.4K -$81.3K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -$52.5K -$68.4K -$81.3K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$52.5K -$68.4K -$81.3K
 
Basic EPS (Cont. Ops) -- -- -$0.00 -$0.01 -$0.02
Diluted EPS (Cont. Ops) -- -- -$0.00 -$0.01 -$0.02
Weighted Average Basic Share -- -- $12.1M $13.3M $26.3M
Weighted Average Diluted Share -- -- $12.1M $13.3M $26.3M
 
EBITDA -- -- -$52.5K -$69.7K -$82.5K
EBIT -- -- -$52.5K -$69.7K -$82.5K
 
Revenue (Reported) -- -- -- $620 $5.5K
Operating Income (Reported) -- -- -$52.5K -$69.7K -$82.5K
Operating Income (Adjusted) -- -- -$52.5K -$69.7K -$82.5K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- -- -- -- $20.8K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- $1.7K $20.8K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $344.2K $292.3K
Other Inc / (Exp) -- -- -- -- -$506.8K
Operating Expenses -- -- -- $344.2K $292.3K
Operating Income -- -- -- -$342.5K -$271.5K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$336.9K -$774.3K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $800 $500
Net Income to Company -- -- -- -$337.7K -$774.8K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$337.7K -$774.8K
 
Basic EPS (Cont. Ops) -- -- -- -$0.04 -$0.08
Diluted EPS (Cont. Ops) -- -- -- -$0.04 -$0.08
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -$342.5K -$271.5K
EBIT -- -- -- -$342.5K -$271.5K
 
Revenue (Reported) -- -- -- -- $20.8K
Operating Income (Reported) -- -- -- -$342.5K -$271.5K
Operating Income (Adjusted) -- -- -- -$342.5K -$271.5K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- -- -- $620 $5.5K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- $620 $5.5K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $52.5K $70.3K $88K
Other Inc / (Exp) -- -- -- -- $1.2K
Operating Expenses -- -- $52.5K $70.3K $88K
Operating Income -- -- -$52.5K -$69.7K -$82.5K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$52.5K -$68.4K -$81.3K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -$52.5K -$68.4K -$81.3K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$52.5K -$68.4K -$81.3K
 
Basic EPS (Cont. Ops) -- -- -$0.00 -$0.01 -$0.02
Diluted EPS (Cont. Ops) -- -- -$0.00 -$0.01 -$0.02
Weighted Average Basic Share -- -- $12.1M $13.3M $26.3M
Weighted Average Diluted Share -- -- $12.1M $13.3M $26.3M
 
EBITDA -- -- -$52.5K -$69.7K -$82.5K
EBIT -- -- -$52.5K -$69.7K -$82.5K
 
Revenue (Reported) -- -- -- $620 $5.5K
Operating Income (Reported) -- -- -$52.5K -$69.7K -$82.5K
Operating Income (Adjusted) -- -- -$52.5K -$69.7K -$82.5K
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents -- -- -- $1.4K $8.7K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $380 $11.3K
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $570 $1.5K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $542.2K $21.6K
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $542.2K $21.6K
 
Accounts Payable -- -- -- $36.9K $49.2K
Accrued Expenses -- -- $7K $2.7K --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- $500 $530
Total Current Liabilities -- -- $7K $40.1K $50K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $7K $40.1K $50K
 
Common Stock -- -- $1.2K $1.3K $1.4K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -$7K $502.1K -$28.4K
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -$7K $502.1K -$28.4K
 
Total Liabilities and Equity -- -- -- $542.2K $21.6K
Cash and Short Terms -- -- -- $1.4K $8.7K
Total Debt -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents -- -- -- $82.3K $8.1K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $2.2K $5.8K
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $3.4K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $686.4K $17.3K
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $686.4K $17.3K
 
Accounts Payable -- -- -- $88K $49.3K
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- $190 $30
Total Current Liabilities -- -- -- $88.2K $49.4K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $88.2K $49.4K
 
Common Stock -- -- -- $1.4K $9.6K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $598.1K -$32K
 
Total Liabilities and Equity -- -- -- $686.4K $17.3K
Cash and Short Terms -- -- -- $82.3K $8.1K
Total Debt -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -$1M -$321.8K -$761.8K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$4.7K -$16.9K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$48.9K -$293.6K -$256.9K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$527.7K -$3.8K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $43.9K $85.3K $89.9K
Cash From Financing -- -- $43.9K $854.6K $276.9K
 
Beginning Cash (CF) -- -- -- -- $1.4K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $33.3K $16.2K
Ending Cash (CF) -- -- -- $1.4K $8.7K
 
Levered Free Cash Flow -- -- -$48.9K -$293.6K -$256.9K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -$52.5K -$68.4K -$81.3K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$3.2K $5K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$55.5K -$18.3K -$75.9K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$512.2K -$109.1K --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $34.5K $22.5K $76.3K
Cash From Financing -- -- $803.7K $209.6K $76.3K
 
Beginning Cash (CF) -- -- -- $1.4K $8.7K
Foreign Exchange Rate Adjustment -- -- -$35.3K -$1.2K -$960
Additions / Reductions -- -- $236.1K $82.1K $330
Ending Cash (CF) -- -- $200.8K $82.3K $8.1K
 
Levered Free Cash Flow -- -- -$55.5K -$18.3K -$75.9K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -- -$337.7K -$774.8K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$7.9K -$8.6K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$256.5K -$314.5K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$124.6K $105.3K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $73.3K $143.6K
Cash From Financing -- -- -- $260.4K $143.6K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$120.7K -$65.6K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -$256.5K -$314.5K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -$52.5K -$68.4K -$81.3K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$3.2K $5K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$55.5K -$18.3K -$75.9K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$512.2K -$109.1K --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $34.5K $22.5K $76.3K
Cash From Financing -- -- $803.7K $209.6K $76.3K
 
Beginning Cash (CF) -- -- -- $1.4K $8.7K
Foreign Exchange Rate Adjustment -- -- -$35.3K -$1.2K -$960
Additions / Reductions -- -- $236.1K $82.1K $330
Ending Cash (CF) -- -- $200.8K $82.3K $8.1K
 
Levered Free Cash Flow -- -- -$55.5K -$18.3K -$75.9K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock